BCAR1 and breast cancer: As a matter of fact, in the highly invasive A17 mouse mammary tumor cells, p130Cas/BCAR1 silencing induces loss of mesenchymal features and acquirement of epithelial-like traits, including the re-expression of the cell-cell adhesion molecule E-cadherin, thus affecting the EMT process involved in cancer progression.